PH30109A - Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same - Google Patents
Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the sameInfo
- Publication number
- PH30109A PH30109A PH46601A PH46601A PH30109A PH 30109 A PH30109 A PH 30109A PH 46601 A PH46601 A PH 46601A PH 46601 A PH46601 A PH 46601A PH 30109 A PH30109 A PH 30109A
- Authority
- PH
- Philippines
- Prior art keywords
- production
- crystalline hydrate
- triazolylthiomethylthio
- hydroclhloride
- cephalosporin
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229930186147 Cephalosporin Natural products 0.000 title 1
- 229940124587 cephalosporin Drugs 0.000 title 1
- 150000001780 cephalosporins Chemical class 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
7 beta -[(Z)-2-(2-Amino 4 thiazolyl)-2-hydroxyiminoacetamido]-3-(1,2,3-triazol-4-yl)thiomethylth io-3-cephem-4-carboxylic acid hydrochloride and its crystalline hydrate, which have a potent antibiotic activity and are low toxic and pharmaceutically stable, thereby useful as an active ingredient of clinically useful antibiotic formulations, and the production thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20496592 | 1992-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH30109A true PH30109A (en) | 1996-12-27 |
Family
ID=16499234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH46601A PH30109A (en) | 1992-07-31 | 1993-07-29 | Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5407929A (en) |
| EP (1) | EP0581552B1 (en) |
| KR (1) | KR100245938B1 (en) |
| CN (1) | CN1037683C (en) |
| AT (1) | ATE165360T1 (en) |
| AU (1) | AU657866B2 (en) |
| BR (1) | BR9303235A (en) |
| CA (1) | CA2101502A1 (en) |
| DE (1) | DE69318077T2 (en) |
| ES (1) | ES2115725T3 (en) |
| FI (1) | FI933391A (en) |
| GR (1) | GR3026699T3 (en) |
| HU (1) | HU219637B (en) |
| IL (1) | IL106516A (en) |
| MX (1) | MX9304611A (en) |
| NO (1) | NO303734B1 (en) |
| NZ (1) | NZ248285A (en) |
| PH (1) | PH30109A (en) |
| PL (2) | PL172835B1 (en) |
| RU (1) | RU2118959C1 (en) |
| TW (1) | TW307769B (en) |
| UA (1) | UA37181C2 (en) |
| ZA (1) | ZA935529B (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU230382B1 (en) * | 2001-02-24 | 2016-03-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivative, production and use thereof as a medicament |
| AT413282B (en) * | 2002-02-01 | 2006-01-15 | Sandoz Ag | CRYSTALLINE SALTS OF 7 - (((5-AMINO-1,2,4-THIADIAZOL-3-YL) (FLUOROMETHOXY-IMINO) ACETYL) AMINO) -3- ((IMINO-1-PIPERAZINYLMETHYL) |
| KR20030076759A (en) * | 2002-03-21 | 2003-09-29 | 주식회사 엘지생명과학 | Novel cephalosporin compounds and process for preparing same |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US6727277B1 (en) | 2002-11-12 | 2004-04-27 | Kansas State University Research Foundation | Compounds affecting cholesterol absorption |
| DE202004021379U1 (en) | 2003-02-12 | 2008-02-21 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of pitivastatin calcium |
| WO2004085444A1 (en) | 2003-03-27 | 2004-10-07 | Basilea Pharmaceutica Ag | Cephalosporin in crystalline form |
| US7501426B2 (en) * | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (en) * | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines |
| DE102005035891A1 (en) * | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8- (3-amino-piperidin-1-yl) -xanthines, their preparation and their use as pharmaceuticals |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| NZ619413A (en) | 2006-05-04 | 2015-08-28 | Boehringer Ingelheim Int | Polymorphs of a dpp-iv enzyme inhibitor |
| PE20110235A1 (en) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | PHARMACEUTICAL COMBINATIONS INCLUDING LINAGLIPTIN AND METMORPHINE |
| ES2733348T3 (en) * | 2007-08-17 | 2019-11-28 | Boehringer Ingelheim Int | Purine derivatives for use in the treatment of diseases related to FAP |
| AR071175A1 (en) * | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INHIBITOR OF DIPEPTIDIL-PEPTIDASA-4 (DPP4) AND A COMPARING PHARMACO |
| PE20100156A1 (en) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | NAFLD TREATMENT |
| KR20190016601A (en) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | Treatment for diabetes in patients inappropriate for metformin therapy |
| UY32030A (en) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "TREATMENT FOR DIABETES IN INAPPROPRIATE PATIENTS FOR THERAPY WITH METFORMIN" |
| CA2735562C (en) * | 2008-08-15 | 2017-10-17 | Boehringer Ingelheim International Gmbh | Dpp-4 inhibitors for wound healing |
| RU2011113823A (en) | 2008-09-10 | 2012-10-20 | БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) | COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| JP2012512848A (en) | 2008-12-23 | 2012-06-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Salt forms of organic compounds |
| AR074990A1 (en) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | TREATMENT OF DIABETES IN PATIENTS WITH AN INAPPROPRIATE GLUCEMIC CONTROL THROUGH METFORMIN THERAPY |
| JP2013512229A (en) | 2009-11-27 | 2013-04-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Treatment of diabetic patients whose genotype has been identified with DDP-IV inhibitors such as linagliptin |
| BR112012028136A2 (en) | 2010-05-05 | 2016-08-09 | Boehringer Ingelheim Int | combination therapy |
| EP3725325B1 (en) | 2010-06-24 | 2023-05-31 | Boehringer Ingelheim International GmbH | Diabetes therapy |
| US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
| CN103781788B (en) | 2011-07-15 | 2016-08-17 | 勃林格殷格翰国际有限公司 | Quinazoline, its preparation and the purposes in pharmaceutical composition thereof being substituted |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| EP3685839A1 (en) | 2012-05-14 | 2020-07-29 | Boehringer Ingelheim International GmbH | Linagliptin for use in the treatment of albuminuria and kidney related diseases |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| EP3110449B1 (en) | 2014-02-28 | 2023-06-28 | Boehringer Ingelheim International GmbH | Medical use of a dpp-4 inhibitor |
| MX2018015089A (en) | 2016-06-10 | 2019-05-13 | Boehringer Ingelheim Int | Combinations of linagliptin and metformin. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE65926B1 (en) * | 1990-07-19 | 1995-11-29 | Shionogi & Co | Thioalkylthio cephalosporin derivatives |
-
1993
- 1993-07-26 ES ES93305864T patent/ES2115725T3/en not_active Expired - Lifetime
- 1993-07-26 DE DE69318077T patent/DE69318077T2/en not_active Expired - Fee Related
- 1993-07-26 TW TW082105942A patent/TW307769B/zh active
- 1993-07-26 EP EP93305864A patent/EP0581552B1/en not_active Expired - Lifetime
- 1993-07-26 AT AT93305864T patent/ATE165360T1/en not_active IP Right Cessation
- 1993-07-27 US US08/097,205 patent/US5407929A/en not_active Expired - Fee Related
- 1993-07-27 UA UA93003172A patent/UA37181C2/en unknown
- 1993-07-28 IL IL106516A patent/IL106516A/en not_active IP Right Cessation
- 1993-07-28 HU HU9302194A patent/HU219637B/en not_active IP Right Cessation
- 1993-07-28 AU AU44227/93A patent/AU657866B2/en not_active Ceased
- 1993-07-28 CA CA002101502A patent/CA2101502A1/en not_active Abandoned
- 1993-07-29 FI FI933391A patent/FI933391A/en unknown
- 1993-07-29 PH PH46601A patent/PH30109A/en unknown
- 1993-07-29 PL PL93299870A patent/PL172835B1/en unknown
- 1993-07-29 NZ NZ24828593A patent/NZ248285A/en unknown
- 1993-07-29 PL PL93317972A patent/PL172830B1/en unknown
- 1993-07-30 MX MX9304611A patent/MX9304611A/en unknown
- 1993-07-30 KR KR1019930014742A patent/KR100245938B1/en not_active IP Right Cessation
- 1993-07-30 NO NO932745A patent/NO303734B1/en unknown
- 1993-07-30 BR BR9303235A patent/BR9303235A/en not_active Application Discontinuation
- 1993-07-30 RU RU93047027/04A patent/RU2118959C1/en not_active IP Right Cessation
- 1993-07-30 ZA ZA935529A patent/ZA935529B/en unknown
- 1993-07-31 CN CN93117437A patent/CN1037683C/en not_active Expired - Fee Related
-
1998
- 1998-04-23 GR GR980400753T patent/GR3026699T3/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU657866B2 (en) | Triazolylthiomethylthio cephalosporin hydrochloride, its crystalline hydrate and the production of the same | |
| AU616838B2 (en) | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro- 2h-benzopyran or dihydrobenzodioxin)carboxamide derivatives | |
| CA2030433A1 (en) | New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases | |
| AU4236889A (en) | Imidazoline derivative and preparation thereof | |
| MY104937A (en) | Cephalosporin derivatives and processes for their preparation | |
| IL91001A0 (en) | N-alkyl derivatives of antibiotic bu-3608 complex and pharmaceutical compositions containing them | |
| EP0342423A3 (en) | Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics | |
| EP0416810A3 (en) | Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates | |
| EP0416814A3 (en) | Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates | |
| NZ218227A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
| HUT53654A (en) | Process for producing cefemcarboxylic acid compounds and pharmaceutical compositions comprising such compounds | |
| EP0652220A4 (en) | Cephalosporin derivative. |